Journal
ONCOGENE
Volume 27, Issue 54, Pages 6866-6874Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2008.324
Keywords
PAR1; p53; protease; promoter activity; transcription factor
Funding
- Israel Science Foundation by the Israel Academy of Science and Humanities
- The Israel Cancer Association
- MECC (Middle East Cancer Consortium)
Ask authors/readers for more resources
Human protease-activated receptor 1(hPar1) is a bonafide receptor of the hemostatic protease thrombin, and has a central function in tumor progression. Inactivation of the tumor suppressor gene p53 is one of the most common genomic alterations occurring in cancer. Here, we address the interrelations between p53 and hPar1 in cancer. We demonstrate an inverse correlation between hPar1 gene expression and wild-type (wt) p53 levels, and a direct correlation with levels of the mutant (mt) p53. Bioinformatic search revealed the presence of at least two p53 motifs in the hPar1 promoter. Indeed, temperature-sensitive (ts) p53 forms reduced hPar1 promoter activity on wt p53 expression. Ectopic introduction of the p53R175H mutant into cells lacking p53 caused a moderate two-fold induction of hPar1 promoter activity. Chromatin immunoprecipitation (ChIP) analyses confirmed a physical association between the p53 protein and hPar1 chromatin fragments. In parallel, PAR1 function is attenuated by p53, as shown by inhibition of pFAK levels and a Matrigel invasion assay. Ectopic reinforcement of hPar1 rescued the inhibition conferred by p53, confirming that p53 directly affects hPar1 expression and function. Altogether, we provide evidence for a direct binding between p53 and hPar1 chromatin, and assign hPar1 as a target of p53. Oncogene (2008) 27, 6866-6874; doi: 10.1038/onc.2008.324; published online 29 September 2008
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available